BlueCrest Capital Management’s Insulet PODD Stock Holding History

BlueCrest Capital Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-700	Closed	-$223K	–	304
2023 Q1	$223K	Buy	+700	New	+$207K	0.01%	250
2019 Q4	–	Sell	-1,215	Closed	-$200K	–	548
2019 Q3	$200K	Buy	+1,215	New	+$171K	0.01%	492
2018 Q4	–	Sell	-29,209	Closed	-$3.1M	–	1299
2018 Q3	$3.1M	Sell	29,209 -45,087	-61%	-$4.22M	0.08%	167
2018 Q2	$6.37M	Buy	74,296 +71,857	+2,946%	+$6.44M	0.17%	134
2018 Q1	$211K	Buy	+2,439	New	+$189K	0.01%	1256

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlueCrest Capital Management's PODD Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Insulet (PODD) in Q2 2023, closing a stake of 700 shares — an estimated $223K sold.

BlueCrest Capital Management first reported a position in PODD in Q1 2018 and held it in 5 quarters. The position peaked at $6.37M in Q2 2018. 578 funds tracked by Wall St. Rank hold PODD as of Q2 2023.

BlueCrest Capital Management reported no remaining Insulet position as of Q2 2023 after selling out during the quarter.
BlueCrest Capital Management sold 700 Insulet shares in Q2 2023, an estimated $223K.
BlueCrest Capital Management first reported a position in Insulet in Q1 2018 and held it in 5 quarters.
BlueCrest Capital Management's Insulet position peaked at $6.37M in Q2 2018.
578 funds tracked by Wall St. Rank held Insulet as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.